Combined estrogen-progestogen cotraceptives and combined estrogen-progestogen menopausal therapy

Author(s)

• World Health Organization
• International Agency for Research on Cancer
• IARC Working Group on the Evaluation of Carcinogenic Risks to Humans

Bibliographic Information

Combined estrogen-progestogen cotraceptives and combined estrogen-progestogen menopausal therapy

（IARC monographs on the evaluation of carcinogenic risks to humans, v. 91）

IARC, 2007

Note

At head of title: World Health Organization, International Agency for Research on Cancer

"This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 7-14 June 2005" -- T.p.

Includes references (p. 332-372)

Details

• NCID: BA86687025
• ISBN:
  • 9789283212911
• Country Code: fr
• Title Language Code: eng
• Text Language Code: eng
• Place of Publication: Lyon
• Pages/Volumes: ix, 528 p.
• Size: 24 cm
• Subject Headings:
  • LCSH : Progestational hormones -- Carcinogenicity
  • LCSH : Progestational hormones -- Side effects
  • LCSH : Catechol estrogens -- Carcinogenicity
  • LCSH : Catechol estrogens -- Side effects
  • LCSH : Contraception -- Complications
  • LCSH : Menopause -- Hormone therapy -- Complications
  • LCSH : Chemical carcinogenesis
  • LCSH : Cancer -- Risk factors
  • LCSH : Women -- Diseases -- Risk factors
• Parent Bibliography ID:
  • BA05101891